Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer.
about
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionMicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancerMicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancerMethodological challenges in utilizing miRNAs as circulating biomarkersAltered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infectionSelection and validation of reference genes for miRNA expression studies during porcine pregnancyCirculating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant MesotheliomaPancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levelsValidation of reference genes for quantitative RT-PCR studies of gene expression in perennial ryegrass (Lolium perenne L.).Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer.Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer.Identification of novel miRNAs and miRNA expression profiling in embryogenic tissues of Picea balfouriana treated by 6-benzylaminopurine.miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinomaDysregulated miR-183 inhibits migration in breast cancer cells.Selective release of microRNA species from normal and malignant mammary epithelial cells.Regulation of neutrophil senescence by microRNAs.The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancerMicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.Biologic profiling of lymph node negative breast cancers by means of microRNA expression.Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.Reference miRNAs for miRNAome analysis of urothelial carcinomas.Altered microRNA expression in bovine subcutaneous and visceral adipose tissues from cattle under different diet.Evaluation of microRNA expression in patient bone marrow aspirate slides.Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cellsIdentification of most stable endogenous control genes for microRNA quantification in the developing mouse lung.Relationship between circulating and tissue microRNAs in a murine model of breast cancerElevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancerCirculating microRNAs as specific biomarkers for breast cancer detection.Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomiamiRNA Biomarkers in Breast Cancer Detection and ManagementmiR-379 regulates cyclin B1 expression and is decreased in breast cancer.Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1)Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.Identification of suitable reference genes for hepatic microRNA quantitationImpact of tumour epithelial subtype on circulating microRNAs in breast cancer patientsCurated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma
P2860
Q21134914-3BEBE063-E366-43DE-9FBE-0293331EE3F3Q21195215-D69BA7B0-B7CB-447A-B610-4C9A74825CAFQ21261323-85FCE06E-E441-4564-B6A4-41C36A87382EQ27027950-D2E57AD1-E54B-47EA-9CBF-83FCFA758E88Q28709053-27839689-F245-454E-A984-10811E10B601Q28741578-79C4976C-EFB3-40D0-A711-B2C7640B8E55Q29248725-C25534EC-2A65-4F05-AFB2-A64327711452Q30502172-7DB72F38-C2D9-484D-9576-795FA60160B6Q33525408-DC6ADB16-6A2A-43E0-BFC0-E54BC37435DAQ33528155-1DB84DD0-B2AB-4087-9ED3-A617CC6075D0Q33642738-ADEB498D-43EF-482B-BB19-415B3FBAA523Q33653041-806D3E18-917D-4381-AD1F-85F83F6C6863Q33653161-A7C7B6B9-FFD7-4E99-9E20-6C9C2B1905E4Q33698660-B921C3D1-89BB-4D00-BA8A-E7F40A435429Q33728084-42F7E04F-6ED5-4D10-A39D-7EE416AAEB94Q33808564-632AC6EF-C677-4C02-8D52-97BA1D8905E2Q33809275-B0FBE333-4DAE-481B-B521-E4ADD955934BQ33847989-084F045A-B134-42C2-9883-79E6933BC809Q33919290-7989660A-B821-40D5-A130-C19CAF0F363BQ34136195-A9FFBEA3-6E6D-487C-9113-515C70E9C2ACQ34181700-AC44563A-F2A9-4606-B361-5A5A58520AB8Q34199722-F68695B2-874C-4825-AAE4-A12752CCF357Q34321313-37119994-90A3-4843-AB2B-94438BF356B9Q34344949-D9D97423-0527-4807-B863-ED31BDB3C3F2Q34389101-2026C65A-061E-44B7-A169-F8F13501D96FQ34415158-6CF8D175-8C8D-43A0-BCC3-BBFFA9FA2EDEQ34450681-38F8D5BA-BFE6-4426-BFD7-62706AAABD92Q34505424-B3842226-5896-4C93-82AC-C5AC5A9C2322Q34526484-8FF44022-94CC-4BC9-A2B1-69DFCCE302B8Q34542335-8DFD816A-F761-42F1-A4E7-F1406DD0E1FFQ34599011-BB560E25-08AE-4217-909B-1E217ACCCDC9Q34771896-06753BDE-2F0C-4C41-B472-FAB40D58DD53Q34850908-FCA26E5B-A102-4AAE-9EA5-00E04880D50BQ35055533-1AFFF76D-DDF2-416D-AE02-6D650210C985Q35082591-F37CF468-28AC-461F-8B79-0B6147F9C3DAQ35092050-BFE88792-28EC-4DF5-938E-D5176CC6C18CQ35113989-D21EBB66-ED46-4429-89DA-E74C31D5A8ACQ35120108-E0313FE0-207A-4B97-A4CD-838370083DDEQ35140145-E6D99BB8-B835-435F-9CB2-467EA8F26E45Q35169747-08C56AA6-EA81-43F1-83B7-E6F3DDEA657A
P2860
Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Identification of suitable end ...... alysis in human breast cancer.
@ast
Identification of suitable end ...... alysis in human breast cancer.
@en
type
label
Identification of suitable end ...... alysis in human breast cancer.
@ast
Identification of suitable end ...... alysis in human breast cancer.
@en
prefLabel
Identification of suitable end ...... alysis in human breast cancer.
@ast
Identification of suitable end ...... alysis in human breast cancer.
@en
P2093
P2860
P356
P1476
Identification of suitable end ...... alysis in human breast cancer.
@en
P2093
Aoife J Lowery
Michael J Kerin
Nicola Miller
Pamela A Davoren
Roisin E McNeill
P2860
P2888
P356
10.1186/1471-2199-9-76
P577
2008-08-21T00:00:00Z
P5875
P6179
1021859007